Search for " " - Xconomy

Results for “ ”

Entry	Author	Date	Location
FDA Flags Risk of Infection, Kidney Damage for Sarepta Duchenne Drugs	Frank Vinluan	01/22/20	Boston
Emendo Eyes the Clinic for CRISPR Therapy That Makes Single-Gene Edits	Frank Vinluan	01/22/20	New York
Of Science and Sea Urchins: Researchers Plumb Oceans for Biological Insights	Melissa Fassbender	01/21/20	Boston
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers	Frank Vinluan	01/17/20	San Francisco
Bio Roundup: EQRx’s Ambitions, Nektar No Vote, New Frazier Fund & More	Frank Vinluan	01/17/20	National
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal	Frank Vinluan	01/16/20	Boston
Mayo Clinic Joins $60M Financing for Biomedical Software Firm nference	Melissa Fassbender	01/16/20	Boston
FDA Panel Votes Down Nektar Opioid Painkiller, Asks for More Data	Frank Vinluan	01/14/20	National
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline	Frank Vinluan	01/14/20	New York
Biogen Adds Another Neuro Drug to Pipeline in Deal With Pfizer	Melissa Fassbender	01/13/20	Boston
Generation Bio Pockets $110M for Next Wave of Gene Therapy, IPO Plans	Frank Vinluan	01/13/20	Boston
Biotech Roundup: Drug Pricing Promises, Bone Disease Data, IPO Plans & More	Sarah de Crescenzo	01/10/20	National
Biogen Teams Up With Startup CAMP4 to Scout for New Neuro Drugs	Frank Vinluan	01/10/20	Boston
Solid Bio Restructures to Get Halted Gene Therapy Study Back on Track	Frank Vinluan	01/09/20	Boston
Novome Lands $33M to Tweak a Gut Microbe Into a Metabolic Therapy	Frank Vinluan	01/08/20	San Francisco
Apellis Rare Blood Disease Drug Tops Alexion’s in Head-to-Head Test	Frank Vinluan	01/07/20	Boston
Takeda to Fund AI Projects at MIT as Part of New 3-Year Collaboration	Melissa Fassbender	01/07/20	Boston
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic	Frank Vinluan	01/07/20	Boston
BioIntervene Raises $30M to Move Nerve Pain Drug Into the Clinic	Sarah de Crescenzo	01/07/20	San Diego
Merck Ramps Up KRAS Chase Through Licensing Deal With Taiho, Astex	Frank Vinluan	01/06/20	New York
Bio Roundup: FDA Approvals, Intrexon’s Shift, Melinta Bankruptcy & More	Frank Vinluan	01/03/20	National
No More Fish or Fruit: Intrexon Turns SynBio Focus to Human Health	Frank Vinluan	01/02/20	National
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal	Sarah de Crescenzo	12/23/19	Boston
Bio Roundup: Amarin’s Approval, FTC v. Illumina, a $120M Deal & More	Sarah de Crescenzo	12/20/19	National
Biogen Strikes Alzheimer’s Deal, Paying $45M for Ionis Tau Drug Rights	Sarah de Crescenzo	12/19/19	San Diego
Takeda Pays Turnstone $120M to Start Alliance on Viral Cancer Therapies	Frank Vinluan	12/19/19	New York
Ring Therapeutics Launches to Expand Gene Therapy Viral Vector Options	Sarah de Crescenzo	12/19/19	Boston
Zafgen’s Path Forward Is Reverse Merger With Chondrial Therapeutics	Frank Vinluan	12/18/19	Boston
Triplet Therapeutics Unveils $59M to Try Hairpin Fix for Huntington’s	Frank Vinluan	12/17/19	Boston
Organovo’s Demise Offers Path for Tarveda to Join the Public Markets	Sarah de Crescenzo	12/16/19	San Diego
Page 1 of 628	next page »

Underwriters and Partners

Xpertise: Watch + Learn

Sponsored · Whitepaper
Time Savings That Speed up Science
Monitor spending and save meaningful dollars with life sciences-specific rewards
Brex

Sponsored · Whitepaper
What’s Next in Neuroscience Therapies
New approaches & tech are on the horizon that could change how researchers and clinicians approach brain and neurological disorders